MR
Max Reinhardt
President, Global Spine

Max Reinhardt insider trades: Orthofix Medical (OFIX) stock sales

President, Global Spine, Orthofix Medical Last trade Mar 5, 2026 17 Form 4 filings
$27K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2020
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Max reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 5, 2026OFIX↓ Sell$27K
Jun 11, 2025OFIX↓ Sell$19K
Jun 7, 2023PCRX↓ Sell$83K
Oct 7, 2022PCRX↓ Sell$80K
Jun 7, 2022PCRX↓ Sell$324K
Apr 21, 2022PCRX↓ Sell$720K
Apr 20, 2022PCRX↓ Sell$2.1M
Jul 2, 2021PCRX↓ Sell$25K
Jun 7, 2021PCRX↓ Sell$212K
Jan 6, 2021PCRX↓ Sell$7K
Nov 13, 2020PCRX↓ Sell$1.6M
Sep 17, 2020PCRX↓ Sell$1.5M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other OFIX insiders

Open-market trades in the last 12 months

About Max Reinhardt's insider trades

Max Reinhardt is President, Global Spine at Orthofix Medical (OFIX). Since Sep 17, 2020, Max has reported no open-market purchases and 12 sales worth $6.7M on SEC Form 4. In the last 12 months: 1 sale ($27K).

Their filings also include grants and awards (6 filings), option exercises (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OFIX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.